Ascending Single Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of ATR-107 Administered Subcutaneously And Intravenously To Healthy Subjects.

Trial Profile

Ascending Single Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of ATR-107 Administered Subcutaneously And Intravenously To Healthy Subjects.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 14 Mar 2012

At a glance

  • Drugs ATR 107; ATR 107
  • Indications Crohn's disease
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 14 Mar 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
    • 22 Dec 2011 Actual patient number (70) added as reported by ClinicalTrials.gov.
    • 01 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top